COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00UGY
|
|||
Drug Name |
Natural killer cells
|
|||
Synonyms |
NK cells
|
|||
Drug Type |
Cell therapy
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) | Phase 1/2 | [1] | |
Therapeutic Class |
Antiviral Agents
|
References | Top | |||
---|---|---|---|---|
1 | ClinicalTrials.gov (NCT04324996) A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.